SecBot SecBot
SECBOTREPLAY Home › Report › PLRX

PLRX · Pliant Therapeutics' $300 million shelf registration, including a $50…

PLIANT THERAPEUTICS, INC. · EFFECT filed Apr 7, 2026 at 00:15 ET

At the news

NEUTRALIMPACT 4/10

EFFECT filed Apr 7, 2026 at 00:15 ET

Pliant Therapeutics' $300 million shelf registration, including a $50 million at-the-market (ATM) offering program, has become effective. The company can now sell securities from time to time over the next three years, creating potential for future dilution.

  • Shelf registration (Form S-3) has become effective, allowing Pliant Therapeutics to raise up to $300 million in capital over the next three years.
  • Of the $300 million, $50 million is designated for an at-the-market (ATM) offering program with Leerink Partners LLC.
  • Securities offered may include common stock, preferred stock, debt, units, and warrants, with specific terms disclosed in future prospectus supplements.
  • The effectiveness allows the company to access capital markets opportunistically, but no immediate offering has been announced.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access